These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids. Mortimer KJ; Tattersfield AE Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541 [TBL] [Abstract][Full Text] [Related]
23. [Inhaled corticosteroids in COPD and the risk of pneumonia]. Niţu M; Medregoniu D; Olteanu M; Golli A; Olteanu M; Măceşeanu A; Medregoniu R Pneumologia; 2010; 59(2):74-6. PubMed ID: 20695361 [TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroids and pneumonia in COPD: an association looking for evidence. Turner MO Am J Respir Crit Care Med; 2008 Mar; 177(5):555-6; author reply 556. PubMed ID: 18296470 [No Abstract] [Full Text] [Related]
25. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease]. Nishimura K Nihon Rinsho; 2003 Dec; 61(12):2181-6. PubMed ID: 14674330 [TBL] [Abstract][Full Text] [Related]
26. "Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document. Alcázar Navarrete B; Casanova C; Miravitlles M; de Lucas P; Riesco JA; Rodríguez González-Moro JM; Arch Bronconeumol; 2015 Apr; 51(4):193-8. PubMed ID: 25540900 [TBL] [Abstract][Full Text] [Related]
27. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]. Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663 [TBL] [Abstract][Full Text] [Related]
28. Developments in inhaled combination therapies: patent activity 2013-2014. Norman P Expert Opin Ther Pat; 2015; 25(11):1239-45. PubMed ID: 26135360 [TBL] [Abstract][Full Text] [Related]
29. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness. Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831 [TBL] [Abstract][Full Text] [Related]
32. Inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Wall J; Aziz I JAMA; 2009 Apr; 301(14):1432-3; author reply 1433-4. PubMed ID: 19351933 [No Abstract] [Full Text] [Related]
33. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes. Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507 [TBL] [Abstract][Full Text] [Related]
34. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma]. Kimura T; Adachi M Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144 [TBL] [Abstract][Full Text] [Related]
35. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192 [TBL] [Abstract][Full Text] [Related]
36. Caution with inhaled corticosteroids in childhood asthma. Welch MJ West J Med; 1995 Oct; 163(4):371-2. PubMed ID: 7483599 [No Abstract] [Full Text] [Related]
37. [Inhaled corticotherapy in asthma: when should it be started and how to stop?]. Aubier M Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645 [TBL] [Abstract][Full Text] [Related]